[Endogenous candida endophthalmitis: a new therapy].
A thirty-year-old patient underwent an extensive abdominal surgery because of a precancerosis due to a colitis ulcerosa. An accompanying smoldering panuveitis led under immunosuppressive therapy to the loss of sight of one eye. Only an increasing vitritis of the second eye allowed the diagnosis of an endogenous Candida endophthalmitis (ECE) following a vitrectomy. A systemic administration of the common antifungal medications was impossible because of the patient's pathological blood-picture and a severe cholestasis. We report the successful use of Fluconazol (Diflucan), an antimycotic agent we never used before in this connection.
Mistlberger
A
A
Augenabteilung der Landeskrankenanstalten Salzburg.
Graf
B
B
D000328:Adult; D002177:Candidiasis / Q000188:drug therapy*; D003093:Colitis, Ulcerative / Q000601:surgery*; D003111:Colonic Polyps / Q000601:surgery*; D004334:Drug Administration Schedule; D009877:Endophthalmitis / Q000188:drug therapy*; D015725:Fluconazole / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009894:Opportunistic Infections / Q000188:drug therapy*; D011183:Postoperative Complications / Q000188:drug therapy*; D014792:Visual Acuity / Q000187:drug effects
D015725:Fluconazole
Endogene Candida-Endophthalmitis: eine neue Therapie.